Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Haemonetics (HAE) Grows on Strong Plasma, Competition Rife

Despite stiff competition, Haemonetics (HAE) grows on the back of its Plasma and Haemonetics Management franchises.

PETS : 38.67 (-1.98%)
MYGN : 32.88 (-1.59%)
ALGN : 253.89 (-0.40%)
HAE : 57.99 (+1.17%)
Haemonetics (HAE) Q2 Earnings Beat Estimates, EPS View Up

Continued momentum in new business generation and geographical expansions help Haemonetics (HAE) deliver strong results in Q2.

PETS : 38.67 (-1.98%)
LMNX : 21.51 (-1.06%)
ISRG : 392.48 (-0.34%)
HAE : 57.99 (+1.17%)
Haemonetics (HAE) in Focus: Stock Moves 10% Higher

Haemonetics (HAE) saw its shares rise nearly 10% on the day after the company reported better-than-expected second quarter and first Half Fiscal 2018 results.

TRUMY : 43.5900 (+4.66%)
HAE : 57.99 (+1.17%)
Haemonetics 2nd Quarter and 1st Half Fiscal 2018 Earnings Release Available on Investor Relations Website

Haemonetics Corporation (NYSE: HAE) announced that second quarter and first half fiscal 2018 financial results are available on its Investor relations website.

HAE : 57.99 (+1.17%)
Robert E. Abernathy Joins Haemonetics Board of Directors

Haemonetics Corporation (NYSE: HAE) announced the election of Robert E. Abernathy, a seasoned healthcare executive, to its Board of Directors. Mr. Abernathy has led major medical businesses in North America...

HYH : 45.69 (+0.53%)
HAE : 57.99 (+1.17%)
HAE Crosses Above Average Analyst Target

In recent trading, shares of Haemonetics Corp. have crossed above the average analyst 12-month target price of $43.50, changing hands for $44.87/share.

HAE : 57.99 (+1.17%)
Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International

Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International

LKQ : 37.75 (+0.21%)
HON : 146.49 (-0.27%)
MRK : 55.20 (+0.05%)
EMN : 89.74 (-0.45%)
HAE : 57.99 (+1.17%)
Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International

Zacks.com featured highlights include Merck, Haemonetics, LKQ, Eastman Chemical and Honeywell International

LKQ : 37.75 (+0.21%)
HON : 146.49 (-0.27%)
MRK : 55.20 (+0.05%)
EMN : 89.74 (-0.45%)
HAE : 57.99 (+1.17%)
Top Stocks with Big Potential Catch-Up Moves

Top Stocks with Big Potential Catch-Up Moves

LKQ : 37.75 (+0.21%)
HON : 146.49 (-0.27%)
MRK : 55.20 (+0.05%)
EMN : 89.74 (-0.45%)
HAE : 57.99 (+1.17%)
Top Stocks with Big Potential Catch-Up Moves

Top Stocks with Big Potential Catch-Up Moves

LKQ : 37.75 (+0.21%)
HON : 146.49 (-0.27%)
MRK : 55.20 (+0.05%)
EMN : 89.74 (-0.45%)
HAE : 57.99 (+1.17%)
Interesting HAE Put And Call Options For November 17th

Investors in Haemonetics Corp. saw new options become available today, for the November 17th expiration.

HAE : 57.99 (+1.17%)
Haemonetics Appoints David J. Wilson Plasma Business Unit President

Haemonetics Corporation (NYSE:HAE) announced the appointment of David J. Wilson as President, Plasma Business Unit, effective September 18, 2017.

HAE : 57.99 (+1.17%)
Haemonetics Grows on Strong Plasma, Blood Center Sluggish

Haemonetics' (HAE) encouraging growth in both Plasma and Haemonetics Management franchises keeps the market upbeat. However, slow revenue growth at the Blood Center franchise raises concern.

EW : 107.09 (-0.01%)
LNTH : 22.35 (+2.29%)
IDXX : 154.88 (+0.52%)
HAE : 57.99 (+1.17%)
HAE Crosses Above Average Analyst Target

In recent trading, shares of Haemonetics Corp. have crossed above the average analyst 12-month target price of $41.80, changing hands for $41.84/share.

HAE : 57.99 (+1.17%)
Haemonetics to Present at Morgan Stanley's Global Healthcare Conference

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley's Global Healthcare Conference in New York on Monday, September 11, 2017 at 4:50pm Eastern...

MS : 48.70 (+0.21%)
HAE : 57.99 (+1.17%)
Haemonetics to Present at Morgan Stanley's Global Healthcare Conference

BRAINTREE, Mass. , Aug. 29, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will present at Morgan Stanley's Global Healthcare Conference...

HAE : 57.99 (+1.17%)
Medtronic (MDT) Beats Q1 Earnings, Misses Revenue Estimates

Medtronic (MDT) rides high in Q1 on strength in three major business segments.

EW : 107.09 (-0.01%)
IDXX : 154.88 (+0.52%)
MDT : 79.49 (+0.29%)
HAE : 57.99 (+1.17%)
Haemonetics Plasma Arm Grows Strong, Blood Center Sluggish

Haemonetics (HAE) registers strong top-line growth, banking on Plasma, TEG, hemostasis management as well as a strong cash position. Blood Center drag continues.

EW : 107.09 (-0.01%)
STE : 87.85 (-0.05%)
ALGN : 253.89 (-0.40%)
HAE : 57.99 (+1.17%)
Cardiovascular Systems Unveils Favorable LIBERTY 360 Data

LIBERTY 360 Study shows the importance of endovascular intervention in patients with Critical Limb Ischemia (CLI) to prevent amputation.

SYK : 155.40 (-0.69%)
LNTH : 22.35 (+2.29%)
HAE : 57.99 (+1.17%)
CSII : 24.38 (+2.70%)
Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink's Company

Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink's Company

CC : 52.50 (+1.84%)
HAE : 57.99 (+1.17%)
BCO : 78.75 (+1.09%)

Van Meerten Stock Picks

My 5 Favorite Small Caps
This morning I wanted to find the 5 Small Cap Stocks that had the best returns over the past year but still appeared to have some more room to climb.
SEDG -0.20 , GDOT +0.11 , CTRL -1.36 , ESIO -0.65 , QNST +0.23
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ17 -0.06% ) this morning are down 0.06% on concern Special Counsel Mueller's criminal investigation between Trump campaign officials and Russia is deepening. Two people familiar with the matter... Read More

Chart of the Day

Chart of the Day

D R Horton (DHI) is the Barchart Chart of the Day.  The home builder has a Trend Spotter buy signal, a Weighted Alpha of 77.13+ and gained 68.46% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed Friday with most contracts 4 – 6 1/2 cents higher, as Dec came back to only lose a half cent on the week. Pre-weekend profit taking gets some of the credit. The CFTC report on Friday showed the spec funds holding a new recor...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart